Healthcare -
Biotechnology - NASDAQ - US
$ 63.75
-1.65 %
$ 3.5 B
Market Cap
-31.87
P/E
ACLX - CASH & EQUIVALENTS
Cash & Equivalents ACLX - Arcellx, Inc.
395 M
LAST VALUE
94.21%
2 YEAR CAGR
93.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR